Formulation, Characterization, and Stability of Protein Drugs: Case Histories: Case Histories
Leading scientists offer detailed profiles of ten protein drugs currently in development. The case histories of these important new compounds are described from the perspective of their formulation, characterization, and stability. This ready reference also features recent data and an abundance of p...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Boston, MA
Springer US
2002
|
| Series: | Pharmaceutical Biotechnology
9 |
| Subjects: | |
| Online Access: | UBR01 Volltext |
| Summary: | Leading scientists offer detailed profiles of ten protein drugs currently in development. The case histories of these important new compounds are described from the perspective of their formulation, characterization, and stability. This ready reference also features recent data and an abundance of previously unpublished information. The in-depth coverage includes a highly useful compendium of degradation sites occurring in over 70 proteins. An invaluable aid in the rapid identification of potential 'hot spots' in proteins, this accessible compilation allows for inspection of the protein's primary structure and preparation of a hydroflex plot |
| Physical Description: | 1 Online-Ressource (XXVIII, 432 p) |
| ISBN: | 9780306474521 |
| DOI: | 10.1007/b112935 |
Staff View
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046149160 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190906s2002 |||| o||u| ||||||eng d | ||
| 020 | |a 9780306474521 |9 978-0-306-47452-1 | ||
| 024 | 7 | |a 10.1007/b112935 |2 doi | |
| 035 | |a (ZDB-2-SBL)978-0-306-47452-1 | ||
| 035 | |a (OCoLC)1118994407 | ||
| 035 | |a (DE-599)BVBBV046149160 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 615 |2 23 | |
| 084 | |a VX 5600 |0 (DE-625)147801:253 |2 rvk | ||
| 245 | 1 | 0 | |a Formulation, Characterization, and Stability of Protein Drugs: Case Histories |b Case Histories |c edited by Rodney Pearlman, Y. John Wang |
| 264 | 1 | |a Boston, MA |b Springer US |c 2002 | |
| 300 | |a 1 Online-Ressource (XXVIII, 432 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Pharmaceutical Biotechnology |v 9 | |
| 520 | |a Leading scientists offer detailed profiles of ten protein drugs currently in development. The case histories of these important new compounds are described from the perspective of their formulation, characterization, and stability. This ready reference also features recent data and an abundance of previously unpublished information. The in-depth coverage includes a highly useful compendium of degradation sites occurring in over 70 proteins. An invaluable aid in the rapid identification of potential 'hot spots' in proteins, this accessible compilation allows for inspection of the protein's primary structure and preparation of a hydroflex plot | ||
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Pharmacy | |
| 650 | 4 | |a Toxicology | |
| 650 | 4 | |a Pharmacy | |
| 650 | 0 | 7 | |a Proteine |0 (DE-588)4076388-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelstabilität |0 (DE-588)4122835-2 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Proteine |0 (DE-588)4076388-2 |D s |
| 689 | 0 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 2 | |a Arzneimittelstabilität |0 (DE-588)4122835-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Pearlman, Rodney |4 edt | |
| 700 | 1 | |a Wang, Y. John |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781475770476 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780306453328 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781475770469 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/b112935 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SBL | ||
| 940 | 1 | |q ZDB-2-SBL_2000/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031529337 | ||
| 966 | e | |u https://doi.org/10.1007/b112935 |l UBR01 |p ZDB-2-SBL |q ZDB-2-SBL_2000/2004 |x Verlag |3 Volltext | |
Record in the Search Index
| _version_ | 1804180490357309440 |
|---|---|
| any_adam_object | |
| author2 | Pearlman, Rodney Wang, Y. John |
| author2_role | edt edt |
| author2_variant | r p rp y j w yj yjw |
| author_facet | Pearlman, Rodney Wang, Y. John |
| building | Verbundindex |
| bvnumber | BV046149160 |
| classification_rvk | VX 5600 |
| collection | ZDB-2-SBL |
| ctrlnum | (ZDB-2-SBL)978-0-306-47452-1 (OCoLC)1118994407 (DE-599)BVBBV046149160 |
| dewey-full | 615 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615 |
| dewey-search | 615 |
| dewey-sort | 3615 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| doi_str_mv | 10.1007/b112935 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02666nmm a2200553zcb4500</leader><controlfield tag="001">BV046149160</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190906s2002 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780306474521</subfield><subfield code="9">978-0-306-47452-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/b112935</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SBL)978-0-306-47452-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1118994407</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046149160</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VX 5600</subfield><subfield code="0">(DE-625)147801:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Formulation, Characterization, and Stability of Protein Drugs: Case Histories</subfield><subfield code="b">Case Histories</subfield><subfield code="c">edited by Rodney Pearlman, Y. John Wang</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">Springer US</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XXVIII, 432 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Pharmaceutical Biotechnology</subfield><subfield code="v">9</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Leading scientists offer detailed profiles of ten protein drugs currently in development. The case histories of these important new compounds are described from the perspective of their formulation, characterization, and stability. This ready reference also features recent data and an abundance of previously unpublished information. The in-depth coverage includes a highly useful compendium of degradation sites occurring in over 70 proteins. An invaluable aid in the rapid identification of potential 'hot spots' in proteins, this accessible compilation allows for inspection of the protein's primary structure and preparation of a hydroflex plot</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Proteine</subfield><subfield code="0">(DE-588)4076388-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelstabilität</subfield><subfield code="0">(DE-588)4122835-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Proteine</subfield><subfield code="0">(DE-588)4076388-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelstabilität</subfield><subfield code="0">(DE-588)4122835-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pearlman, Rodney</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Y. John</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781475770476</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780306453328</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781475770469</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/b112935</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SBL_2000/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031529337</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/b112935</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="q">ZDB-2-SBL_2000/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046149160 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:35Z |
| institution | BVB |
| isbn | 9780306474521 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031529337 |
| oclc_num | 1118994407 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XXVIII, 432 p) |
| psigel | ZDB-2-SBL ZDB-2-SBL_2000/2004 ZDB-2-SBL ZDB-2-SBL_2000/2004 |
| publishDate | 2002 |
| publishDateSearch | 2002 |
| publishDateSort | 2002 |
| publisher | Springer US |
| record_format | marc |
| series2 | Pharmaceutical Biotechnology |
| spelling | Formulation, Characterization, and Stability of Protein Drugs: Case Histories Case Histories edited by Rodney Pearlman, Y. John Wang Boston, MA Springer US 2002 1 Online-Ressource (XXVIII, 432 p) txt rdacontent c rdamedia cr rdacarrier Pharmaceutical Biotechnology 9 Leading scientists offer detailed profiles of ten protein drugs currently in development. The case histories of these important new compounds are described from the perspective of their formulation, characterization, and stability. This ready reference also features recent data and an abundance of previously unpublished information. The in-depth coverage includes a highly useful compendium of degradation sites occurring in over 70 proteins. An invaluable aid in the rapid identification of potential 'hot spots' in proteins, this accessible compilation allows for inspection of the protein's primary structure and preparation of a hydroflex plot Pharmacology/Toxicology Pharmacy Toxicology Proteine (DE-588)4076388-2 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Arzneimittelstabilität (DE-588)4122835-2 gnd rswk-swf Proteine (DE-588)4076388-2 s Arzneimittel (DE-588)4003115-9 s Arzneimittelstabilität (DE-588)4122835-2 s DE-604 Pearlman, Rodney edt Wang, Y. John edt Erscheint auch als Druck-Ausgabe 9781475770476 Erscheint auch als Druck-Ausgabe 9780306453328 Erscheint auch als Druck-Ausgabe 9781475770469 https://doi.org/10.1007/b112935 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Formulation, Characterization, and Stability of Protein Drugs: Case Histories Case Histories Pharmacology/Toxicology Pharmacy Toxicology Proteine (DE-588)4076388-2 gnd Arzneimittel (DE-588)4003115-9 gnd Arzneimittelstabilität (DE-588)4122835-2 gnd |
| subject_GND | (DE-588)4076388-2 (DE-588)4003115-9 (DE-588)4122835-2 |
| title | Formulation, Characterization, and Stability of Protein Drugs: Case Histories Case Histories |
| title_auth | Formulation, Characterization, and Stability of Protein Drugs: Case Histories Case Histories |
| title_exact_search | Formulation, Characterization, and Stability of Protein Drugs: Case Histories Case Histories |
| title_full | Formulation, Characterization, and Stability of Protein Drugs: Case Histories Case Histories edited by Rodney Pearlman, Y. John Wang |
| title_fullStr | Formulation, Characterization, and Stability of Protein Drugs: Case Histories Case Histories edited by Rodney Pearlman, Y. John Wang |
| title_full_unstemmed | Formulation, Characterization, and Stability of Protein Drugs: Case Histories Case Histories edited by Rodney Pearlman, Y. John Wang |
| title_short | Formulation, Characterization, and Stability of Protein Drugs: Case Histories |
| title_sort | formulation characterization and stability of protein drugs case histories case histories |
| title_sub | Case Histories |
| topic | Pharmacology/Toxicology Pharmacy Toxicology Proteine (DE-588)4076388-2 gnd Arzneimittel (DE-588)4003115-9 gnd Arzneimittelstabilität (DE-588)4122835-2 gnd |
| topic_facet | Pharmacology/Toxicology Pharmacy Toxicology Proteine Arzneimittel Arzneimittelstabilität |
| url | https://doi.org/10.1007/b112935 |
| work_keys_str_mv | AT pearlmanrodney formulationcharacterizationandstabilityofproteindrugscasehistoriescasehistories AT wangyjohn formulationcharacterizationandstabilityofproteindrugscasehistoriescasehistories |